Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 11 | 2024 | 317 | 2.220 |
Why?
|
| Caenorhabditis elegans | 8 | 2024 | 138 | 1.290 |
Why?
|
| Molecular Dynamics Simulation | 4 | 2020 | 33 | 0.940 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 206 | 0.930 |
Why?
|
| Indans | 2 | 2020 | 8 | 0.840 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 157 | 0.790 |
Why?
|
| Thiadiazoles | 1 | 2020 | 19 | 0.730 |
Why?
|
| Ubiquitination | 1 | 2019 | 43 | 0.690 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 75 | 0.660 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 95 | 0.660 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2018 | 56 | 0.660 |
Why?
|
| Proteins | 2 | 2018 | 345 | 0.630 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 143 | 0.600 |
Why?
|
| Signal Transduction | 4 | 2024 | 1622 | 0.600 |
Why?
|
| Replication Origin | 1 | 2017 | 10 | 0.590 |
Why?
|
| RNA, Transfer | 1 | 2017 | 16 | 0.590 |
Why?
|
| Telomerase | 1 | 2017 | 27 | 0.590 |
Why?
|
| DNA Replication | 1 | 2017 | 150 | 0.540 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 113 | 0.540 |
Why?
|
| Molecular Docking Simulation | 6 | 2023 | 75 | 0.520 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 1186 | 0.450 |
Why?
|
| Neurodegenerative Diseases | 3 | 2022 | 78 | 0.450 |
Why?
|
| Animals | 14 | 2024 | 13246 | 0.390 |
Why?
|
| Apolipoprotein E4 | 2 | 2024 | 19 | 0.380 |
Why?
|
| Models, Molecular | 4 | 2019 | 341 | 0.370 |
Why?
|
| Protein Conformation | 3 | 2020 | 168 | 0.370 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2023 | 40 | 0.360 |
Why?
|
| Lysosomes | 2 | 2024 | 84 | 0.360 |
Why?
|
| Ubiquitin | 3 | 2019 | 45 | 0.360 |
Why?
|
| Neoplasms | 1 | 2020 | 1249 | 0.340 |
Why?
|
| Autophagy | 2 | 2024 | 169 | 0.340 |
Why?
|
| Sesquiterpenes | 2 | 2021 | 89 | 0.330 |
Why?
|
| NF-kappa B | 2 | 2021 | 315 | 0.310 |
Why?
|
| Mice | 5 | 2024 | 5759 | 0.310 |
Why?
|
| Brain | 3 | 2023 | 1328 | 0.300 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2018 | 15 | 0.300 |
Why?
|
| Humans | 24 | 2024 | 50208 | 0.280 |
Why?
|
| Protein Binding | 5 | 2018 | 665 | 0.270 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2018 | 117 | 0.260 |
Why?
|
| Binding Sites | 3 | 2021 | 375 | 0.250 |
Why?
|
| 14-3-3 Proteins | 2 | 2022 | 18 | 0.250 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2023 | 43 | 0.220 |
Why?
|
| Catalytic Domain | 2 | 2020 | 57 | 0.220 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 7 | 0.210 |
Why?
|
| Profilins | 2 | 2023 | 16 | 0.210 |
Why?
|
| Apoptosis | 2 | 2020 | 1112 | 0.210 |
Why?
|
| Glioblastoma | 1 | 2024 | 93 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 86 | 0.200 |
Why?
|
| Cell Line | 3 | 2020 | 1021 | 0.200 |
Why?
|
| Benzylamines | 1 | 2021 | 15 | 0.190 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 26 | 0.190 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2021 | 7 | 0.190 |
Why?
|
| Alkaloids | 1 | 2021 | 32 | 0.190 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 586 | 0.190 |
Why?
|
| Phosphorylation | 5 | 2021 | 534 | 0.180 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 103 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 288 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2020 | 21 | 0.180 |
Why?
|
| HL-60 Cells | 1 | 2020 | 18 | 0.180 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 13 | 0.180 |
Why?
|
| RNA | 1 | 2021 | 171 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 81 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 396 | 0.170 |
Why?
|
| Enzyme Activation | 1 | 2019 | 275 | 0.170 |
Why?
|
| Protein Transport | 1 | 2019 | 183 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2019 | 91 | 0.160 |
Why?
|
| Protein Unfolding | 1 | 2018 | 6 | 0.160 |
Why?
|
| Mutation | 3 | 2023 | 1294 | 0.160 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 401 | 0.160 |
Why?
|
| Somatomedins | 1 | 2018 | 32 | 0.160 |
Why?
|
| Tetrazoles | 1 | 2018 | 40 | 0.160 |
Why?
|
| Hippocampus | 2 | 2021 | 228 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 1416 | 0.150 |
Why?
|
| Triazoles | 1 | 2018 | 109 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2018 | 353 | 0.150 |
Why?
|
| DNA | 1 | 2021 | 541 | 0.150 |
Why?
|
| Nucleotide Motifs | 1 | 2017 | 24 | 0.150 |
Why?
|
| Mitochondria | 1 | 2020 | 404 | 0.140 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.140 |
Why?
|
| Computational Biology | 1 | 2018 | 216 | 0.140 |
Why?
|
| Muscles | 1 | 2016 | 102 | 0.140 |
Why?
|
| Insulin | 1 | 2018 | 456 | 0.130 |
Why?
|
| Benzylidene Compounds | 1 | 2016 | 4 | 0.130 |
Why?
|
| Aspirin | 1 | 2017 | 114 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1586 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 828 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 140 | 0.130 |
Why?
|
| Molecular Structure | 3 | 2021 | 296 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1013 | 0.120 |
Why?
|
| Amyloid beta-Peptides | 3 | 2021 | 65 | 0.120 |
Why?
|
| Proteasome Inhibitors | 1 | 2014 | 104 | 0.110 |
Why?
|
| Computer Simulation | 3 | 2018 | 280 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 1378 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 106 | 0.100 |
Why?
|
| Aging | 1 | 2016 | 688 | 0.100 |
Why?
|
| RNA Interference | 3 | 2016 | 179 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 1108 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 605 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 140 | 0.090 |
Why?
|
| Thermodynamics | 2 | 2021 | 33 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2021 | 213 | 0.080 |
Why?
|
| Aged | 2 | 2019 | 9405 | 0.080 |
Why?
|
| Male | 4 | 2023 | 25399 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2020 | 232 | 0.070 |
Why?
|
| Cell Death | 2 | 2016 | 182 | 0.060 |
Why?
|
| Female | 3 | 2020 | 26635 | 0.060 |
Why?
|
| Proteomics | 2 | 2018 | 330 | 0.060 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2023 | 17 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2023 | 20 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 106 | 0.050 |
Why?
|
| Exosomes | 1 | 2023 | 50 | 0.050 |
Why?
|
| Tubulin | 1 | 2023 | 23 | 0.050 |
Why?
|
| Microtubules | 1 | 2023 | 45 | 0.050 |
Why?
|
| Electrophorus | 1 | 2021 | 5 | 0.050 |
Why?
|
| Butyrylcholinesterase | 1 | 2021 | 8 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2021 | 19 | 0.050 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 30 | 0.050 |
Why?
|
| Horses | 1 | 2021 | 44 | 0.050 |
Why?
|
| Lactones | 1 | 2021 | 26 | 0.050 |
Why?
|
| Protein Folding | 1 | 2021 | 49 | 0.050 |
Why?
|
| Myocardium | 1 | 2023 | 438 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 1458 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2020 | 9 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2021 | 126 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 69 | 0.040 |
Why?
|
| Glioma | 1 | 2021 | 79 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 123 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2019 | 38 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 72 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 90 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 173 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 249 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 349 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 31 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 49 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 35 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 37 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 453 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 1819 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 428 | 0.040 |
Why?
|
| Drug Design | 1 | 2018 | 121 | 0.040 |
Why?
|
| Actins | 1 | 2018 | 119 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 14 | 0.040 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 29 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 609 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 72 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 73 | 0.040 |
Why?
|
| Peptides | 1 | 2018 | 223 | 0.040 |
Why?
|
| Acetylation | 1 | 2017 | 97 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 550 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2018 | 306 | 0.040 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
|
| Detergents | 1 | 2016 | 17 | 0.030 |
Why?
|
| tau Proteins | 1 | 2016 | 26 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 26 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 71 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 534 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 205 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 115 | 0.030 |
Why?
|
| Lipids | 1 | 2016 | 148 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 212 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 13324 | 0.030 |
Why?
|
| Fertility | 1 | 2014 | 28 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 113 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 831 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 48 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 613 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1108 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 601 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1126 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1179 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 3154 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 3981 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 12206 | 0.010 |
Why?
|